New York 2025-2026 Regular Session

New York Assembly Bill A07311

Introduced

3/25/25

Refer

3/25/25

Refer

1/7/26

Caption

Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.

Latest NY A07311 Activity

View All Events: NY 2025-2026 Regular Session A07311

Companion Bills

No companion bills found.

Previously Filed As

NY SB78

Public Health – Prostate–Specific Antigen Testing (Protect Our Prostate Act)

NY HB3057

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

NY A3117

Requires health insurance coverage for testing for BRCA1 and BRCA2 genes.

NY HB1112

Require the coverage of biomarker testing in certain health insurance policies.

NY S2247

Requires non-invasive prenatal testing for pregnant persons and health insurance coverage for non-invasive prenatal testing.

NY HB830

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage

NY HB06895

An Act Concerning Health Benefit Review And Requiring Health Insurance Coverage For Biomarker Testing.

NY LD107

An Act to Require Health Insurance Coverage for Biomarker Testing

NY S01282

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY A01439

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

Similar Bills

No similar bills found.